Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Ibex Technologies presents data on heparin neutralization agent

May 21, 1997

Selective thrombin inhibitors revealed by HMR

May 21, 1997

Searle describes antiplatelet agents

May 20, 1997

3-D describes potent and selective thrombin inhibitors

May 15, 1997

Factor Xa inhibitors from 3-D

May 15, 1997

Fibrinogen antagonists reported by Lilly/Cor Therapeutics

May 14, 1997

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

Serine protease inhibitors described by 3-D

May 12, 1997

BMS and Sanofi seek U.S. and European approval for clopidogrel

May 8, 1997

Genentech plans phase III studies of second-generation t-PA

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...